In the fully adjusted model (Model 3), the odds ratios were 0.345 (95% CI: 0.211–0.565) for Q2, 0.126 (95% CI: 0.071–0.223) for Q3, and 0.126 (95% CI: 0.065–0.241) for Q4, with a significant trend observed across quartiles (P for trend < 0.0001; Table 2 ).
← all excerpts
Association between platelet-to-neutrophil ratio and asthma-COPD overlap: a cross-sectional study in China.
1
—
—